Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
VENGLUSTAT
Not marketed
Congenital cystic kidney disease
LTS15823NANCT04705051Tabulated Results
VENGLUSTAT
Not marketed
Healthy Volunteer
PKM16116NAChiCTR2200066559 Publication
VIGABATRIN
Sabril
Infantile Spasms
EFC12369NAEudraCT: 2017-000230-62Tabulated Results
VIGABATRIN
Sabril
Infantile Spasms
LTS12745NAEudraCT: 2017-000611-17Tabulated Results
VOCIPROTAFIB
Not marketed
Metastatic Neoplasm
TCD16210NANCT04418661Tabulated Results
XALIPRODEN
Not marketed
Neurology
EFC2724NANCT00104013Summary
XALIPRODEN
Not marketed
Neurology
EFC2946NANCT00103649Summary
ZOLPIDEM
Ambien, Stilnox
Sleep disorders
EFC5202NANCT00630175Summary
ZOLPIDEM
Ambien, Stilnox
Attention/Deficit Disorder
EFC6820ZOLKIDSNCT00318448Summary
ZOLPIDEM
Ambien, Stilnox
Sleep Disorders
L_8445NANCT00530556Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted